HBK Investments’s Foundation Medicine, Inc. FMI Stock Holding History

HBK Investments’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,700	Closed	-$764K	–	1246
2018 Q1	$764K	Buy	+9,700	New	+$716K	0.01%	678
2015 Q2	–	Sell	-8,342	Closed	-$401K	–	1178
2015 Q1	$401K	Buy	+8,342	New	+$378K	﹤0.01%	794

Other funds holding FMI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

HBK Investments's FMI Position: Q2 2018 in Review

HBK Investments sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 9,700 shares — an estimated $764K sold.

HBK Investments first reported a position in FMI in Q1 2015 and held it in 2 quarters. The position peaked at $764K in Q1 2018. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.

HBK Investments reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
HBK Investments sold 9,700 Foundation Medicine, Inc. shares in Q2 2018, an estimated $764K.
HBK Investments first reported a position in Foundation Medicine, Inc. in Q1 2015 and held it in 2 quarters.
HBK Investments's Foundation Medicine, Inc. position peaked at $764K in Q1 2018.
157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.

Based on HBK Investments's 13F filing for Q2 2018, filed 14 Aug 2018.